CLINICAL TRIAL: PHASE II STUDY TO COMPARE TWICE DAILY AND ONCE DAILY THERAPY AND

临床试验：比较每日两次和每日一次治疗的第二阶段研究

• 批准号: 7716788
• 负责人: KRISTINE B. PATTERSON
• 金额: $ 0.06万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-02 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716788
• 关键词: Adverse effects; Affect; Anti-HIV Agents; Blood; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Daily; Funding; Grant; HIV; Institution; Pharmaceutical Preparations; Phase; Purpose; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Viral Load result

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to compare the effects of three anti-HIV drugs in decreasing the amount of HIV in the blood (HIV viral load), and to see how these drugs might affect people taking them (side effects).

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的目的是比较三种抗HIV药物在减少血液中HIV量（HIV病毒载量）中的影响，并查看这些药物如何影响服用艾滋病毒（副作用）。